Bharat Parenterals Ltd — Updates, 24-04-2025: Company Update

Bharat Parenterals Limited has announced a board meeting to discuss the successful completion of its acquisition of Varenyam Healthcare Pvt. Ltd., now a wholly owned subsidiary. This share swap involved the issuance of 351,255 equity shares of BPL in exchange for 250,000 shares of VHPL, which is projected to contribute ₹60 crore in revenue and ₹10 crore in EBITDA for FY2025-26. This acquisition is part of a strategic initiative to streamline the company’s structure and enhance its operational control, positioning it favorably in the pharmaceutical market. Investor sentiment may improve due to the anticipated synergies and strengthened market presence.